Frequency of Pneumonia in Children Presenting with Measles at Bacha Khan Medical College Swabi
DOI:
https://doi.org/10.70749/ijbr.v3i7.2528Keywords:
Measles, Pneumonia, Vaccination, Children, Public HealthAbstract
Measles remains a leading cause of preventable childhood morbidity and mortality worldwide, particularly in low- and middle-income countries. Despite the availability of an effective vaccine, outbreaks persist due to inadequate immunization coverage and socioeconomic disparities. Pneumonia is one of the most severe complications of measles, significantly contributing to hospitalizations and deaths among children. This cross-sectional study aimed to determine the frequency of pneumonia among children presenting with measles at Bacha Khan Medical Complex, Swabi, from December 2024 to May 2025. A total of 118 clinically and serologically confirmed measles patients aged 1–8 years were enrolled using a consecutive sampling technique. Data were analyzed using IBM SPSS version 25, with significance set at p ≤ 0.05. Results showed that 52 (44.1%) of the children developed pneumonia. The condition was significantly associated with younger age (≤5 years, p = 0.02), lack of vaccination (p = 0.001), and low socioeconomic status (p = 0.04). Radiological evaluation revealed bilateral patchy consolidation in 71.1% of pneumonia cases. These findings indicate that nearly half of the children with measles experienced pneumonia, emphasizing the crucial role of routine immunization and improved socioeconomic conditions in mitigating this burden. Strengthening vaccination programs, enhancing nutritional support, and promoting community-based awareness are essential steps toward reducing measles-related complications and achieving better child health outcomes in resource-limited settings.
Downloads
References
1. Gastañaduy, P. A., Goodson, J. L., Panagiotakopoulos, L., Rota, P. A., Orenstein, W. A., & Patel, M. (2021). Measles in the 21st century: Progress toward achieving and sustaining elimination. The Journal of Infectious Diseases, 224(Supplement_4), S420-S428.
https://doi.org/10.1093/infdis/jiaa793
2. Rabaan, A. A., Mutair, A. A., Alhumaid, S., Garout, M., Alsubki, R. A., Alshahrani, F. S., Alfouzan, W. A., Alestad, J. H., Alsaleh, A. E., Al-Mozaini, M. A., Koritala, T., Alotaibi, S., Temsah, M., Akbar, A., Ahmad, R., Khalid, Z., Muhammad, J., & Ahmed, N. (2022). Updates on measles incidence and eradication: Emphasis on the immunological aspects of measles infection. Medicina, 58(5), 680.
https://doi.org/10.3390/medicina58050680
3. Parums, D. V. (2024). A review of the resurgence of measles, a vaccine-preventable disease, as current concerns contrast with past hopes for measles elimination. Medical Science Monitor, 30.
https://doi.org/10.12659/msm.944436
4. Branda, F., Giovanetti, M., Romano, C., Benvenuto, D., Ciccozzi, A., Sanna, D., Ciccozzi, M., & Scarpa, F. (2024). Global measles surveillance: Trends, challenges, and implications for public health interventions. Infectious Disease Reports, 16(2), 367-379.
https://doi.org/10.3390/idr16020028
5. Packham, A., Taylor, A. E., Karangwa, M., Sherry, E., Muvunyi, C., & Green, C. A. (2024). Measles vaccine coverage and disease outbreaks: A systematic review of the early impact of COVID-19 in low and lower-middle income countries. International Journal of Public Health, 69.
https://doi.org/10.3389/ijph.2024.1606997
6. Adamu, A. A., Jalo, R. I., Masresha, B. G., Ndwandwe, D., & Wiysonge, C. S. (2024). Mapping the implementation determinants of second dose measles vaccination in the World Health Organization African region: A rapid review. Vaccines, 12(8), 896.
https://doi.org/10.3390/vaccines12080896
7. Geremew, T. T., Gezie, L. D., & Abejie, A. N. (2019). Geographical variation and associated factors of childhood measles vaccination in Ethiopia: A spatial and multilevel analysis. BMC Public Health, 19(1).
https://doi.org/10.1186/s12889-019-7529-z
8. Cutts, F. T., Ferrari, M. J., Krause, L. K., Tatem, A. J., & Mosser, J. F. (2021). Vaccination strategies for measles control and elimination: Time to strengthen local initiatives. BMC Medicine, 19(1).
https://doi.org/10.1186/s12916-020-01843-z
9. Conis, E. (2019). Measles and the modern history of vaccination. Public Health Reports®, 134(2), 118-125.
https://doi.org/10.1177/0033354919826558
10. Goodson, J. L., & Seward, J. F. (2015). Measles 50 years after use of measles vaccine. Infectious Disease Clinics of North America, 29(4), 725-743.
https://doi.org/10.1016/j.idc.2015.08.001
11. Kakoullis, L., Sampsonas, F., Giannopoulou, E., Kalogeropoulou, C., Papachristodoulou, E., Tsiamita, M., Lykouras, D., Velissaris, D., Karkoulias, K., Spiropoulos, K., & Panos, G. (2019). Measles‐associated pneumonia and hepatitis during the measles outbreak of 2018. International Journal of Clinical Practice, 74(2).
https://doi.org/10.1111/ijcp.13430
12. Turaiche, M., Grigoras, M. L., Bratosin, F., Bogdan, I., Bota, A. V., Cerbu, B., Gurban, C. V., Wulandari, P. H., Gurumurthy, S., Hemaswini, K., Citu, C., & Marincu, I. (2022). Disease progression, clinical features, and risk factors for pneumonia in unvaccinated children and adolescents with measles: A re-emerging disease in Romania. International Journal of Environmental Research and Public Health, 19(20), 13165.
https://doi.org/10.3390/ijerph192013165
13. Donadel, M., Stanescu, A., Pistol, A., Stewart, B., Butu, C., Jankovic, D., Paunescu, B., & Zimmerman, L. (2021). Risk factors for measles deaths among children during a nationwide measles outbreak – Romania, 2016–2018. BMC Infectious Diseases, 21(1).
https://doi.org/10.1186/s12879-021-05966-3
14. Perret, C., Le Corre, N., & Castro-Rodriguez, J. A. (2021). Emergent pneumonia in children. Frontiers in Pediatrics, 9.
https://doi.org/10.3389/fped.2021.676296
15. Amurri, L., Reynard, O., Gerlier, D., Horvat, B., & Iampietro, M. (2022). Measles virus-induced host immunity and mechanisms of viral evasion. Viruses, 14(12), 2641.
https://doi.org/10.3390/v14122641
16. Cox, R. M., Wolf, J. D., Lieberman, N. A., Lieber, C. M., Kang, H., Sticher, Z. M., Yoon, J., Andrews, M. K., Govindarajan, M., Krueger, R. E., Sobolik, E. B., Natchus, M. G., Gewirtz, A. T., DeSwart, R. L., Kolykhalov, A. A., Hekmatyar, K., Sakamoto, K., Greninger, A. L., & Plemper, R. K. (2024). Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets. Nature Communications, 15(1).
https://doi.org/10.1038/s41467-024-45418-5
17. De Benedictis, F. M., Kerem, E., Chang, A. B., Colin, A. A., Zar, H. J., & Bush, A. (2020). Complicated pneumonia in children. The Lancet, 396(10253), 786-798.
https://doi.org/10.1016/s0140-6736(20)31550-6
18. Shan, W., Shi, T., Chen, K., Xue, J., Wang, Y., Yu, J., Zhao, G., Tian, J., & Zhang, T. (2019). Risk factors for severe community-aquired pneumonia among children hospitalized with CAP younger than 5 years of age. Pediatric Infectious Disease Journal, 38(3), 224-229.
https://doi.org/10.1097/inf.0000000000002098
19. Ren, X., Gamallat, Y., Liu, D., Zhu, Y., Meyiah, A., Yan, C., Shang, D., & Xin, Y. (2020). The distribution characteristics of intestinal microbiota in children with community-acquired pneumonia under five years of age. Microbial Pathogenesis, 142, 104062.
https://doi.org/10.1016/j.micpath.2020.104062
20. Qian, C., Chen, Q., Lin, W., Li, Z., Zhu, J., Zhang, J., Luan, L., Zheng, B., Zhao, G., Tian, J., & Zhang, T. (2024). Incidence of community-acquired pneumonia among children under 5 years in Suzhou, China: A hospital-based cohort study. BMJ Open, 14(1), e078489.
https://doi.org/10.1136/bmjopen-2023-078489
21. Noor, T., Aslam, A., Bhatti, M., Rizwan, S., Ali, W., & Waseem, R. (2019). Prevalence and Outcome of Pneumonia in Children with Measles. Pak J Med Health Sci, 13(2), 216-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
